Thyroid cytology in pediatric patients: a single-center study from 2015 to 2023-is there a necessity for distinct treatment approaches for patients with and without autoimmune thyroiditis?

Monika Kujdowicz, Dominika Janu��, Jan Radli��ski, Aleksandra Kiszka-Wi��koj��, Anna Taczanowska-Niemczuk, Damian M��ynarski, Wojciech G��recki, Jerzy B Starzyk, Dariusz Adamek
Author Information
  1. Monika Kujdowicz: Department of Pathomorphology, Jagiellonian University Medical College, Grzeg��rzecka 16 Street, 31-531, Krakow, Poland. monika.kujdowicz@uj.edu.pl. ORCID
  2. Dominika Janu��: Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  3. Jan Radli��ski: Student Scientific Group of Pediatric Endocrinology, Department of Pediatric and Adolescent Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
  4. Aleksandra Kiszka-Wi��koj��: Department of Pediatric Surgery, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  5. Anna Taczanowska-Niemczuk: Department of Pediatric Surgery, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  6. Damian M��ynarski: Department of Pathomorphology, University Children Hospital in Krakow, Krakow, Poland.
  7. Wojciech G��recki: Department of Pediatric Surgery, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  8. Jerzy B Starzyk: Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  9. Dariusz Adamek: Department of Pathomorphology, Jagiellonian University Medical College, Grzeg��rzecka 16 Street, 31-531, Krakow, Poland.

Abstract

The management of thyroid nodules is guided by the cytological classification provided by The Bethesda System for Reporting Thyroid Cytology. Notably, the biology of thyroid tumors in pediatric patients differs from that in adults, and there is limited research focused on pediatric cases. This study aimed to assess the effectiveness of the Bethesda system in pediatric patients treated at the largest tertiary pediatric thyroid center in Poland between 2015 and 2023. A retrospective analysis was conducted on 566 patients with thyroid nodules, of whom 555 underwent fine-needle aspiration biopsy (FNAB). A total of 217 patients underwent thyroid surgery. Of these, 206 had previously undergone FNAB with cytological evaluation at our center, while 11 patients underwent thyroid surgery due to a RET mutation or the need for an extended procedure. The initial FNAB results showed distribution across Bethesda categories as follows: 7.6% for category I, 54.6% for category II, 20.9% for category III, 4.1% for category IV, 7.6% for category V, and 5.6% for category VI. Among patients who underwent surgery, the distribution of Bethesda categories I through VI was 2.9%, 25.2%, 29.1%, 8.3%, 19.4%, and 15%, respectively. The risk of malignancy (ROM) from the initial FNAB was estimated at 33.3%, 11.5%, 22.2%, 4.8%, 84.4%, and 96.8% for Bethesda categories I through VI, respectively. In patients with autoimmune thyroiditis (AIT), the ROM was higher than in non-AIT patients for Bethesda categories I through IV, while it was lower in category VI. The sensitivity for detecting non-benign neoplasms across Bethesda categories III through VI was approximately 86% in both AIT and non-AIT patients. However, for papillary thyroid carcinoma, sensitivity in Bethesda categories V and VI was 86% in non-AIT patients but decreased to 61.5% in AIT patients. These findings emphasize the importance of considering surgical intervention in pediatric patients with Bethesda III-VI cytology, particularly in those with AIT.

Keywords

References

  1. Niedziela M (2006) Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 13(2):427���453. https://doi.org/10.1677/erc.1.00882 [DOI: 10.1677/erc.1.00882]
  2. Janu�� D, Kujdowicz M, W��jcik M et al (2023) Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma ��� a follow-up study. Front Endocrinol (Lausanne) 14(April):1���13. https://doi.org/10.3389/fendo.2023.1172823 [DOI: 10.3389/fendo.2023.1172823]
  3. Janu�� D, W��jcik M, Taczanowska-Niemczuk A et al (2023) Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000���2022. Front Endocrinol (Lausanne) 14(May):1���17. https://doi.org/10.3389/fendo.2023.1170971 [DOI: 10.3389/fendo.2023.1170971]
  4. Guleria P, Srinivasan R, Rana C, Agarwal S (2022) Molecular landscape of pediatric thyroid cancer: a review. Diagnostics 12(12):1���21. https://doi.org/10.3390/diagnostics12123136 [DOI: 10.3390/diagnostics12123136]
  5. Jarz��b B, Dedecjus M, Lewi��ski A et al (2022) Diagnostyka i leczenie raka tarczycy u chorych doros��ych ��� Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022. Endokrynol Pol. 73(2):173���300. https://doi.org/10.5603/EP.a2022.0028
  6. Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules (1996) The Papanicolaou society of cytopathology task force on standards of practice. Diagn Cytopathol 15(1):84���89. https://doi.org/10.1002/(SICI)1097-0339(199607)15:1%3c84::AID-DC18%3e3.0.CO;2-8 [DOI: 10.1002/(SICI)1097-0339(199607)15]
  7. Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, Vanderlaan PA (2023) The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid 33(9):1039���1044. https://doi.org/10.1089/thy.2023.0141 [DOI: 10.1089/thy.2023.0141]
  8. Hsiao V, Massoud E, Jensen C et al (2022) Diagnostic accuracy of fine-needle biopsy in the detection of thyroid malignancy: a systematic review and meta-analysis. JAMA Surg 157(12):1105���1113. https://doi.org/10.1001/jamasurg.2022.4989 [DOI: 10.1001/jamasurg.2022.4989]
  9. WHO Classification of Tumours Editorial Board (2022) Endocrine and neuroendocrine tumours. 5th ed. International Agency for Research on Cancer.  https://tumourclassification.iarc.who.int/chapters/53
  10. Amin MB, Edge S, Greene F et al (2017) AJCC Cancer Staging Manual, 8th edn. Springer International Publishing
  11. Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25(7):716���759. https://doi.org/10.1089/thy.2014.0460 [DOI: 10.1089/thy.2014.0460]
  12. Bojarsky M, Baran JA, Halada S et al (2023) Outcomes of ATA low-risk pediatric thyroid cancer patients not treated with radioactive iodine therapy. J Clin Endocrinol Metab 108(12):3338���3344. https://doi.org/10.1210/clinem/dgad322 [DOI: 10.1210/clinem/dgad322]
  13. Keefe G, Culbreath K, Cherella CE et al (2022) Autoimmune thyroiditis and risk of malignancy in children with thyroid nodules. Thyroid 32(9):1109���1117. https://doi.org/10.1089/thy.2022.0241 [DOI: 10.1089/thy.2022.0241]
  14. Pasala P, Francis GL (2017) Autoimmune thyroid diseases in children. Expert Rev Endocrinol Metab 12(2):129���142. https://doi.org/10.1080/17446651.2017.1300525 [DOI: 10.1080/17446651.2017.1300525]
  15. De Luca F, Santucci S, Corica D, Pitrolo E, Romeo M, Aversa T (2013) Hashimoto���s thyroiditis in childhood: presentation modes and evolution over time. Ital J Pediatr 39:17���19. https://doi.org/10.1186/1824-7288-39-8 [DOI: 10.1186/1824-7288-39-8]
  16. Ansaldi N, Palmas T, Corrias A et al (2003) Autoimmune thyroid disease and celiac disease in children. J Pediatr Gastroenterol Nutr 37(1):63���66. https://doi.org/10.1097/00005176-200307000-00010 [DOI: 10.1097/00005176-200307000-00010]
  17. Guille JT, Opoku-Boateng A, Thibeault SL, Chen H (2015) Evaluation and management of the solitary thyroid nodule. Oncologist 20:19���27 [DOI: 10.1634/theoncologist.2014-0115]
  18. Heider A, Arnold S, Jing X (2020) Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules experience of a tertiary care referral center. Arch Pathol Lab Med 144(4):473���477. https://doi.org/10.5858/arpa.2018-0596-OA [DOI: 10.5858/arpa.2018-0596-OA]
  19. Koo DH, Song KS, Kwon H et al (2016) (2016) Does tumor size influence the diagnostic accuracy of ultrasound-guided fine-needle aspiration cytology for thyroid nodules? Int J Endocrinol. 1:3803647. https://doi.org/10.1155/2016/3803647 [DOI: 10.1155/2016/3803647]
  20. De Morais NS, Stuart J, Guan H et al (2019) The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer. J Endocr Soc 3(4):791���800. https://doi.org/10.1210/js.2018-00427 [DOI: 10.1210/js.2018-00427]
  21. Boi F, Pani F, Mariotti S (2017) Thyroid autoimmunity and thyroid cancer: review focused on cytological studies. Eur Thyroid J 6(4):178���186. https://doi.org/10.1159/000468928 [DOI: 10.1159/000468928]
  22. Dos Santos Valsecchi VA, Betoni FR, Ward LS, Cunha LL (2024) Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: from the bench to bedside. Rev Endocr Metab Disord 25(1):5���17. https://doi.org/10.1007/s11154-023-09846-w [DOI: 10.1007/s11154-023-09846-w]
  23. Chiari D, Pirali B, Perano V, Leone R, Mantovani A, Bottazzi B (2023) The crossroad between autoimmune disorder, tissue remodeling and cancer of the thyroid: the long pentraxin 3 (PTX3). Front Endocrinol (Lausanne) 14(March):1���6. https://doi.org/10.3389/fendo.2023.1146017 [DOI: 10.3389/fendo.2023.1146017]
  24. Rossi ED, Adeniran AJ, Faquin WC (2019) Pitfalls in thyroid cytopathology. Surg Pathol Clin 12(4):865���881. https://doi.org/10.1016/j.path.2019.08.001 [DOI: 10.1016/j.path.2019.08.001]
  25. Canberk S, Barroca H, Gir��o I et al (2022) Performance of the Bethesda system for reporting thyroid cytology in multi-institutional large cohort of pediatric thyroid nodules: a detailed analysis. Diagnostics. 12(1):179. https://doi.org/10.3390/diagnostics12010179 [DOI: 10.3390/diagnostics12010179]
  26. Strickland KC, Howitt BE, Barletta JA, Cibas ES, Krane JF (2018) Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules. Cancer Cytopathol 126(2):86���93. https://doi.org/10.1002/cncy.21922 [DOI: 10.1002/cncy.21922]
  27. Canini V, Leni D, Pincelli AI et al (2019) (2019) Clinical-pathological issues in thyroid pathology: study on the routine application of NIFTP diagnostic criteria. Sci Rep 9(1):1���9. https://doi.org/10.1038/s41598-019-49851-1 [DOI: 10.1038/s41598-019-49851-1]
  28. Scappaticcio L, Trimboli P, Bellastella G, et al (2023) Prediction of classical versus non classical papillary thyroid carcinoma subtypes from cytology of nodules classified according to TIRADS. Endocrine. Published online 2023. https://doi.org/10.1007/s12020-023-03604-3
  29. Asa SL (2004) My approach to oncocytic tumours of the thyroid. J Clin Pathol 57(3):225���232. https://doi.org/10.1136/jcp.2003.008474 [DOI: 10.1136/jcp.2003.008474]
  30. Vuong HG, Chung DGB, Ngo LM et al (2021) The use of the Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules: a meta-analysis. Thyroid. 31(8):1203���1211. https://doi.org/10.1089/thy.2020.0702 [DOI: 10.1089/thy.2020.0702]

Grants

  1. Status grant of Jagiellonian University no. N41/DBS/001217/The Ministry of Science and Higher Education in Poland

Word Cloud

Created with Highcharts 10.0.0patientsBethesdathyroidcategorypediatriccategoriesVIunderwentFNAB6%AITnodulesThyroidsurgerynon-AITcytologycytologicalstudysystemcenter201511initialdistributionacross79%III41%IVV2%3%4%respectivelymalignancyROM5%8%autoimmunethyroiditissensitivity86%managementguidedclassificationprovidedSystemReportingCytologyNotablybiologytumorsdiffersadultslimitedresearchfocusedcasesaimedassesseffectivenesstreatedlargesttertiaryPoland2023retrospectiveanalysisconducted566555fine-needleaspirationbiopsytotal217206previouslyundergoneevaluationdueRETmutationneedextendedprocedureresultsshowedfollows:54II205Among2252981915%riskestimated33228496higherlowerdetectingnon-benignneoplasmsapproximatelyHoweverpapillarycarcinomadecreased61findingsemphasizeimportanceconsideringsurgicalinterventionIII-VIparticularlypatients:single-center2023-isnecessitydistincttreatmentapproacheswithoutthyroiditis?AutoimmunePediatricRisk

Similar Articles

Cited By